Literature DB >> 1421387

Molecular basis of inherited human antithrombin deficiency.

M A Blajchman1, R C Austin, F Fernandez-Rachubinski, W P Sheffield.   

Abstract

Figures 1 and 4 summarize the various AT mutations that have been described. The molecular elucidation, over the past decade, of the various AT deficiency types has provided important new insights into functional-structural relationships of AT. This knowledge, together with data provided by monoclonal antibodies and x-ray crystallographic studies of related molecules, has provided important new insights as to how the AT molecule functions in vivo. Finally, such knowledge might, in the foreseeable future, lead to the production of AT molecules that are specifically genetically engineered to be of use in a variety of clinical situations.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1421387

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  The Laboratory of Hypercoagulability: A Review of Present-Day Techniques.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-07       Impact factor: 2.300

Review 2.  Coagulation in sepsis.

Authors:  André Amaral; Steven M Opal; Jean-Louis Vincent
Journal:  Intensive Care Med       Date:  2004-05-18       Impact factor: 17.440

Review 3.  Thrombophilia and the surgeon.

Authors:  E G Rhodes
Journal:  Ann R Coll Surg Engl       Date:  1996-07       Impact factor: 1.891

Review 4.  Targeted gene disruption of natural anticoagulant proteins in mice.

Authors:  Tetsuhito Kojima
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

5.  Antithrombin III: summary of first database update.

Authors:  D A Lane; R J Olds; S L Thein
Journal:  Nucleic Acids Res       Date:  1994-09       Impact factor: 16.971

6.  Three novel missense mutations in the antithrombin III (AT3) gene causing recurrent venous thrombosis.

Authors:  D S Millar; A I Wacey; J Ribando; E Melissari; B Laursen; P Woods; V V Kakkar; D N Cooper
Journal:  Hum Genet       Date:  1994-11       Impact factor: 4.132

7.  Year in review 2005: Critical Care - resource management.

Authors:  André Carlos Kajdacsy-Balla Amaral; Gordon D Rubenfeld
Journal:  Crit Care       Date:  2006-06-29       Impact factor: 9.097

8.  The anticoagulant effect of PGI2S and tPA in transgenic umbilical vein endothelial cells is linked to up-regulation of PKA and PKC.

Authors:  Jian-Hua Wang; Lin-Jing Yuan; Zhi-Min Zhong; Zhe-Sheng Wen; Jian-Ming Deng; Rong-Xin Liang; Min Zheng
Journal:  Int J Mol Sci       Date:  2014-02-19       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.